The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatological Therapeutics Market Research Report 2025
Synopsis
The global Dermatological Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Therapeutics.
Report Scope
The Dermatological Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AGI Dermatics
Allergan
Amgen
Chester Valley
Dermik
Eisai
Ferndale
Genentech
Medicis
Onset Therapeutics
Segment by Type
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Dermatological Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Therapeutics.
Report Scope
The Dermatological Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AGI Dermatics
Allergan
Amgen
Chester Valley
Dermik
Eisai
Ferndale
Genentech
Medicis
Onset Therapeutics
Segment by Type
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatological Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti Psoriasis
1.2.5 Anti-acne
1.2.6 Others
1.3 Market by Application
1.3.1 Global Dermatological Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological Therapeutics Market Perspective (2019-2030)
2.2 Dermatological Therapeutics Growth Trends by Region
2.2.1 Global Dermatological Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dermatological Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Dermatological Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Dermatological Therapeutics Market Dynamics
2.3.1 Dermatological Therapeutics Industry Trends
2.3.2 Dermatological Therapeutics Market Drivers
2.3.3 Dermatological Therapeutics Market Challenges
2.3.4 Dermatological Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatological Therapeutics Players by Revenue
3.1.1 Global Top Dermatological Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Dermatological Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Dermatological Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatological Therapeutics Revenue
3.4 Global Dermatological Therapeutics Market Concentration Ratio
3.4.1 Global Dermatological Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatological Therapeutics Revenue in 2023
3.5 Dermatological Therapeutics Key Players Head office and Area Served
3.6 Key Players Dermatological Therapeutics Product Solution and Service
3.7 Date of Enter into Dermatological Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatological Therapeutics Breakdown Data by Type
4.1 Global Dermatological Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Dermatological Therapeutics Forecasted Market Size by Type (2025-2030)
5 Dermatological Therapeutics Breakdown Data by Application
5.1 Global Dermatological Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Dermatological Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dermatological Therapeutics Market Size (2019-2030)
6.2 North America Dermatological Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dermatological Therapeutics Market Size by Country (2019-2024)
6.4 North America Dermatological Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatological Therapeutics Market Size (2019-2030)
7.2 Europe Dermatological Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dermatological Therapeutics Market Size by Country (2019-2024)
7.4 Europe Dermatological Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatological Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Dermatological Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dermatological Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Dermatological Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatological Therapeutics Market Size (2019-2030)
9.2 Latin America Dermatological Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dermatological Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Dermatological Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatological Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Dermatological Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dermatological Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Dermatological Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AGI Dermatics
11.1.1 AGI Dermatics Company Detail
11.1.2 AGI Dermatics Business Overview
11.1.3 AGI Dermatics Dermatological Therapeutics Introduction
11.1.4 AGI Dermatics Revenue in Dermatological Therapeutics Business (2019-2024)
11.1.5 AGI Dermatics Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Dermatological Therapeutics Introduction
11.2.4 Allergan Revenue in Dermatological Therapeutics Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Dermatological Therapeutics Introduction
11.3.4 Amgen Revenue in Dermatological Therapeutics Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Chester Valley
11.4.1 Chester Valley Company Detail
11.4.2 Chester Valley Business Overview
11.4.3 Chester Valley Dermatological Therapeutics Introduction
11.4.4 Chester Valley Revenue in Dermatological Therapeutics Business (2019-2024)
11.4.5 Chester Valley Recent Development
11.5 Dermik
11.5.1 Dermik Company Detail
11.5.2 Dermik Business Overview
11.5.3 Dermik Dermatological Therapeutics Introduction
11.5.4 Dermik Revenue in Dermatological Therapeutics Business (2019-2024)
11.5.5 Dermik Recent Development
11.6 Eisai
11.6.1 Eisai Company Detail
11.6.2 Eisai Business Overview
11.6.3 Eisai Dermatological Therapeutics Introduction
11.6.4 Eisai Revenue in Dermatological Therapeutics Business (2019-2024)
11.6.5 Eisai Recent Development
11.7 Ferndale
11.7.1 Ferndale Company Detail
11.7.2 Ferndale Business Overview
11.7.3 Ferndale Dermatological Therapeutics Introduction
11.7.4 Ferndale Revenue in Dermatological Therapeutics Business (2019-2024)
11.7.5 Ferndale Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Dermatological Therapeutics Introduction
11.8.4 Genentech Revenue in Dermatological Therapeutics Business (2019-2024)
11.8.5 Genentech Recent Development
11.9 Medicis
11.9.1 Medicis Company Detail
11.9.2 Medicis Business Overview
11.9.3 Medicis Dermatological Therapeutics Introduction
11.9.4 Medicis Revenue in Dermatological Therapeutics Business (2019-2024)
11.9.5 Medicis Recent Development
11.10 Onset Therapeutics
11.10.1 Onset Therapeutics Company Detail
11.10.2 Onset Therapeutics Business Overview
11.10.3 Onset Therapeutics Dermatological Therapeutics Introduction
11.10.4 Onset Therapeutics Revenue in Dermatological Therapeutics Business (2019-2024)
11.10.5 Onset Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
